The association between proton pump inhibitor use and systemic anti-tumour therapy on survival outcomes in patients with advanced non-small cell lung cancer: A systematic review and meta-analysis
Br J Clin Pharmacol. 2024 Apr 3. doi: 10.1111/bcp.16060. Online ahead of print.NO ABSTRACTPMID:38570720 | DOI:10.1111/bcp.16060
Source: Clinical Lung Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Proton Pump Inhibitors PPIs